Menu
Search
|

Menu

Close
X

DaShenLin Pharmaceutical Group Co Ltd 603233.SS (Shanghai Stock Exchange)

42.55 CNY
-0.40 (-0.93%)
As of Feb 15
chart
Previous Close 42.95
Open 42.52
Volume 529,758
3m Avg Volume 755,092
Today’s High 43.15
Today’s Low 42.35
52 Week High 77.85
52 Week Low 37.00
Shares Outstanding (mil) 400.01
Market Capitalization (mil) 17,020.43
Forward P/E 32.66
Dividend (Yield %) 0.60 ( 1.41 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.57 Mean rating from 7 analysts

KEY STATS

Revenue (mm, CNY)
FY18
6,299
FY17
7,421
FY16
6,274
EPS (CNY)
FY18
1.030
FY17
1.259
FY16
1.185
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
32.66
33.89
Price to Sales (TTM)
vs sector
2.02
5.98
Price to Book (MRQ)
vs sector
5.80
23.30
Price to Cash Flow (TTM)
vs sector
--
29.44
Total Debt to Equity (MRQ)
vs sector
20.50
16.82
LT Debt to Equity (MRQ)
vs sector
0.00
5.54
Return on Investment (TTM)
vs sector
18.42
61.79
Return on Equity (TTM)
vs sector
18.74
71.03

EXECUTIVE LEADERSHIP

Guangzhi Peng
Chief Financial Officer, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Consumer Non-Cyclicals
Industry: Drug Retailers
Address:

No. 410
410-1, Longxi Avenue, Liwan Dist
GUANGZHOU   GNG   510000

Phone: +8620.81689688

DaShenLin Pharmaceutical Group Co., Ltd. is a China-based company principally engaged in the pharmaceutical retailing business. The Company's primary business includes direct sales and retailing of Chinese and Western medicine, ginseng nourishing herbs and Chinese medicine pieces, health products, medical apparatus and instruments and other commodities. The Company mainly conducts its business within domestic market.

SPONSORED STORIES